<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-18T23:27:48Z</responseDate><request verb="GetRecord" identifier="oai:riubu.ubu.es:10259/10047" metadataPrefix="ese">https://riubu.ubu.es/oai/request</request><GetRecord><record><header><identifier>oai:riubu.ubu.es:10259/10047</identifier><datestamp>2025-01-28T01:05:20Z</datestamp><setSpec>com_10259_6688</setSpec><setSpec>com_10259_5086</setSpec><setSpec>com_10259_2604</setSpec><setSpec>col_10259_6689</setSpec></header><metadata><europeana:record xmlns:europeana="http://www.europeana.eu/schemas/ese/" xmlns:confman="org.dspace.core.ConfigurationManager" xmlns:doc="http://www.lyncode.com/xoai" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.europeana.eu/schemas/ese/ http://www.europeana.eu/schemas/ese/ESE-V3.4.xsd">
<dc:title>Incorporating a Nebulizer System Into High-Flow Nasal Cannula Improves Comfort in Infants With Bronchiolitis</dc:title>
<dc:creator>Valencia Ramos, Juan</dc:creator>
<dc:creator>Mirás, Alicia</dc:creator>
<dc:creator>Cilla, Amaia</dc:creator>
<dc:creator>Ochoa Sangrador, Carlos</dc:creator>
<dc:creator>Arnaez, Juan</dc:creator>
<dc:subject>High-flow oxygen therapy</dc:subject>
<dc:subject>Nebulization</dc:subject>
<dc:subject>Comfort</dc:subject>
<dc:subject>Bronchiolitis</dc:subject>
<dc:subject>Satisfaction</dc:subject>
<dc:subject>Jet nebulizer</dc:subject>
<dc:subject>Aerogen</dc:subject>
<dc:subject>Bronquiolitis</dc:subject>
<dc:subject>Enfermedades infecciosas en niños</dc:subject>
<dc:subject>Communicable diseases in children</dc:subject>
<dc:description>BACKGROUND:&#xd;
High-flow nasal cannula (HFNC) is increasingly used to provide respiratory support in infants with bronchiolitis. The delivery of aerosol therapy through a jet nebulizer is widely indicated despite its controversial efficacy and poor tolerability.&#xd;
METHODS:&#xd;
This randomized cross-over study aimed to evaluate the comfort and satisfaction of the delivery of aerosol therapy using a nebulization system integrated into HFNC compared with the standard practice of using a jet nebulizer with a face mask. The COMFORT-Behavior (COMFORT-B) scale, a visual analog scale, and a numeric rating scale were used by health professionals and caregivers to assess subjects' levels of comfort and satisfaction.&#xd;
RESULTS:&#xd;
A total of 113 nebulizations (64 via nebulizer with HFNC; 49 via jet nebulizer) were delivered to the 6 subjects included in the study. Use of the nebulizer with HFNC showed increased comfort and satisfaction during nebulization compared to use of the jet nebulizer, as measured by the COMFORT-B scale, the visual analog scale, and the numeric rating scale, with the following median (interquartile range) scores: 10.7 (7–16) versus 14.5 (10–20) (P = .006), 8.5 (6–10) versus 7 (4–9) (P = .02), and 3.84 (3.61–4.07) versus 1.83 (1.58–2.08) (P &lt; .001), respectively. Correlation between the COMFORT-B scale and the visual analog scale using Spearman's rho was −0.757 (P &lt; .001). The intraclass correlation coefficient for the COMFORT-B scale, visual analog scale, and numeric rating scale, as measured by 2 different nurses, was between 0.75 and 0.87.&#xd;
CONCLUSIONS:&#xd;
The use of a nebulizer incorporated into HFNC therapy results in an increased level of comfort and satisfaction compared to the use of a conventional jet nebulizer in subjects with bronchiolitis who required HFNC therapy. Further studies are needed to determine whether aerosol therapy delivered through HFNC improves the clinical course of this pathology.</dc:description>
<dc:date>2025-01-27T11:53:31Z</dc:date>
<dc:date>2025-01-27T11:53:31Z</dc:date>
<dc:date>2018</dc:date>
<dc:type>info:eu-repo/semantics/article</dc:type>
<dc:type>info:eu-repo/semantics/acceptedVersion</dc:type>
<dc:identifier>0020-1324</dc:identifier>
<dc:identifier>http://hdl.handle.net/10259/10047</dc:identifier>
<dc:identifier>10.4187/respcare.05880</dc:identifier>
<dc:identifier>1943-3654</dc:identifier>
<dc:language>eng</dc:language>
<dc:relation>Respiratory Care. 2018, V. 63, n. 7, p. 886-893</dc:relation>
<dc:relation>https://doi.org/10.4187/respcare.05880</dc:relation>
<dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
<dc:format>application/pdf</dc:format>
<dc:publisher>María Ana Liebert</dc:publisher>
<europeana:object>https://riubu.ubu.es/bitstream/10259/10047/3/Valencia_rc_2018.pdf.jpg</europeana:object>
<europeana:provider>Hispana</europeana:provider>
<europeana:type>TEXT</europeana:type>
<europeana:rights>http://rightsstatements.org/vocab/CNE/1.0/</europeana:rights>
<europeana:dataProvider>RIUBU. Repositorio Institucional de la Universidad de Burgos</europeana:dataProvider>
<europeana:isShownAt>http://hdl.handle.net/10259/10047</europeana:isShownAt>
</europeana:record></metadata></record></GetRecord></OAI-PMH>